Register entry

LENZ Therapeutics, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
7
Exclusivities
1
Countries
0
Exclusivity

Patents and exclusivities

7
PatentProductCoversExpiry
10052313VIZZaceclidine hydrochlorideproductMar 2034
11179328VIZZaceclidine hydrochlorideuseMar 2034
9844537VIZZaceclidine hydrochlorideproductMar 2034
12653779VIZZaceclidine hydrochlorideuseJun 2035
12128036VIZZaceclidine hydrochlorideuseOct 2039
12533347VIZZaceclidine hydrochlorideuseOct 2039
12414942VIZZaceclidine hydrochlorideuseMar 2044
ProductExclusivityUntil
VIZZACECLIDINE HYDROCHLORIDENCE New chemical entityJul 2030
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
VIZZAceclidinesolution/ drops, ophthalmic84226-100NDA
Enquiry

Common questions

Is LENZ Therapeutics, Inc. FDA approved?
LENZ Therapeutics, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does LENZ Therapeutics, Inc. make?
1 product is listed under LENZ Therapeutics, Inc. in the openFDA NDC Directory, most often as solution/ drops. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.